Skip to main content
DNA Labs India

HBOC Extended Panel [Hereditary Breast And Ovarian Cancer] (32 Genes) Test

DNA Labs India | ISO 9001:2015 Certified

HBOC Extended Panel [Hereditary Breast And Ovarian Cancer] (32 Genes) Test

Short Name: HBOC Extended Panel

Also known as: HBOC Panel, Hereditary Cancer Panel, 32-Gene Breast and Ovarian Cancer Test

HBOC Extended Panel [Hereditary Breast And Ovarian Cancer] (32 Genes) Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Peripheral Blood samples. Results in 4-5 weeks from sample collection. Free home collection in 300+ cities across India.

Genetic TestAdults🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the HBOC Extended Panel test is to identify inherited mutations in 32 genes linked to hereditary breast and ovarian cancer, allowing for early risk assessment, personalized screening, and preventive interventions to reduce cancer incidence and mortality.

Test Code
3019
Price
₹20,000
Sample Type
Peripheral Blood
Result Time
4-5 weeks from sample collection
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No specific preparation is required, but inform your doctor about any medications or recent medical procedures. A doctor's prescription may be needed unless for surgery, pregnancy, or travel abroad cases.

Method: Venipuncture

Step 2

Laboratory Analysis

A healthcare professional will collect a blood sample via venipuncture from a vein in your arm, using an EDTA vacutainer. The process is quick and minimally invasive.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bruising. Resume normal activities immediately. Store the sample in a cool pack if not analyzed immediately.

Timeline: 4-5 weeks from sample collection

Patient Instructions

1
Before the Test:Obtain a doctor's prescription if required. Discuss family history and test implications with a genetic counselor. No fasting is needed.
2
During the Test:A blood sample is drawn in a clinical setting or during home collection. The process takes about 10-15 minutes.
3
After the Test:Results are available in 4-5 weeks. Follow up with a genetic counselor to review results and plan next steps.

About This Test

Who Should Get This Test

The purpose of the HBOC Extended Panel test is to identify inherited mutations in 32 genes linked to hereditary breast and ovarian cancer, allowing for early risk assessment, personalized screening, and preventive interventions to reduce cancer incidence and mortality.

How to Prepare

  • Ensure the patient is relaxed and hydrated
  • Use aseptic technique to avoid contamination
  • Label the sample correctly with patient details
  • Transport the sample to the lab within 24 hours in a cool pack

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This test is crucial for individuals with a family history of breast or ovarian cancer to assess genetic risk and plan preventive measures, such as enhanced screening or prophylactic surgeries."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypePeripheral Blood
Sample Volume2 ml
ContainerEDTA Vacutainer
Collection MethodVenipuncture

Sample Stability

Room Temperature24 hours
Refrigerated (2-8°C)72 hours
Frozen (-20°C)Long-term storage
Sample Rejection Criteria:
  • Sample hemolyzed or clotted
  • Insufficient volume (<2 ml)
  • Incorrect container or labeling
  • Sample older than stability period

Understanding Your Results

Results from the HBOC Extended Panel indicate the presence or absence of pathogenic mutations in the 32 genes tested. A positive result means a mutation was found, increasing cancer risk, while a negative result means no known mutations were detected, though risk may still exist due to other factors.
📊

Positive for Pathogenic Variant

High risk for hereditary breast and ovarian cancer; recommend enhanced screening, genetic counseling, and discussion of preventive options.

📊

Negative for Pathogenic Variants

No known mutations detected in the tested genes; however, family history and other risk factors should still be considered for ongoing monitoring.

📊

Variant of Uncertain Significance (VUS)

A genetic variant was found, but its clinical significance is unknown; recommend periodic re-evaluation and genetic counseling.

📊

Inconclusive

Test could not determine a clear result due to technical issues; may require repeat testing or additional analysis.

⚠️ When to Consult a Doctor:

Consult a doctor or genetic counselor immediately after receiving results to understand implications, plan screening or prevention strategies, and discuss family testing options.

Limitations

  • Does not detect all possible genetic mutations or variants of uncertain significance (VUS)
  • Cannot predict the exact age of cancer onset or severity
  • Results may have psychological impact and require genetic counseling
  • Limited to known genes in the panel; other risk factors not assessed

Risks & Considerations

  • Psychological distress from positive results
  • Potential for false positives or negatives
  • Insurance or discrimination concerns (though legal protections exist)
  • Family implications requiring disclosure

Interfering Factors

  • Poor sample quality due to hemolysis or contamination
  • Recent blood transfusions affecting DNA integrity
  • Use of certain medications that may alter genetic expression
  • Improper sample storage or handling

Compare With Similar Tests

TestHBOC Extended Panel [Hereditary Breast And Ovarian Cancer] (32 Genes)BRCA1/BRCA2 Single Gene TestHereditary Cancer Panel (Other)Direct-to-Consumer Genetic TestSomatic Tumor Testing
ComparisonHBOC Extended Panel [Hereditary Breast And Ovarian Cancer] (32 Genes)

Frequently Asked Questions

What is the HBOC Extended Panel test?
It is a genetic test that analyzes 32 genes associated with hereditary breast and ovarian cancer to identify mutations that increase cancer risk.
Who should consider taking this test?
Individuals with a family history of breast or ovarian cancer, early-onset cancer, male breast cancer, or known mutations in the family.
How is the test performed?
A blood or saliva sample is collected and analyzed using next-generation sequencing (NGS) technology in a certified laboratory.
What does a positive result mean?
A positive result indicates a pathogenic mutation was found, significantly increasing the risk of developing breast and/or ovarian cancer.
What are the risks of the test?
Risks include psychological impact, potential for variants of uncertain significance, and implications for family members.
How long does it take to get results?
Results are typically available within 4-5 weeks after sample collection.
Is the test covered by insurance?
Coverage varies by insurance provider and policy; it is not universally covered, so check with your insurer.
Can men take this test?
Yes, men can carry mutations and pass them on; the test is recommended for men with a family history of breast or ovarian cancer.
What genes are included in the panel?
The panel includes 32 genes such as BRCA1, BRCA2, TP53, PTEN, PALB2, and others linked to hereditary breast and ovarian cancer.
How accurate is the test?
The test uses advanced NGS technology with high accuracy, but no test is 100% foolproof; genetic counseling is advised for interpretation.
What should I do after receiving results?
Consult a genetic counselor or doctor to understand results, plan screening or prevention, and discuss family testing.
Is genetic counseling required before the test?
While not mandatory, genetic counseling is strongly recommended to ensure informed consent and proper understanding of implications.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.